Related Experiment Video
Updated: Aug 29, 2025

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Myrtenol Inhibits Biofilm Formation and Virulence in the Drug-Resistant Acinetobacter baumannii: Insights into the
Lei Liu1,2, Bin Liu1,2, Liang Li1,2
1Department of Respiratory Medicine, the First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, People's Republic of China.
Background:
blaNDM-1-producing Acinetobacter baumannii (BP-AB) remains a critical problem in nosocomial infections, because of its resistance mediated by the biofilm formation and virulence factors. No studies have confirmed myrtenol's efficacy in inhibiting the biofilm formation and virulence associated with biofilm of BP-AB.
Methods:
The tested concentrations of myrtenol were wild type (A), 50 μg/mL (B), 100 μg/mL (C), 200 μg/mL (D), 250 μg/mL (E), and 300 μg/mL (F).
Results:
The BP-AB biofilm inhibition was significantly higher in the D, E, and F groups than in the A, B, and C groups. Myrtenol significantly reduced the air-liquid interface ring formation in glass tubes. It also effectively inhibited the attachment of BP-AB strains on polystyrene surfaces as shown by crystal violet staining. Microscopy showed a significant reduction in biofilm formation with dispersed BP-AB strains. The confocal laser scanning microscopy analysis showed a significant reduction in the biofilm's biomass, covered surface area, and thickness. The scanning electron microscopy analysis revealed significantly fewer BP-AB aggregates on the coverslip surface. In the CompStat analysis, the biofilm's biomass, maximum thickness, and surface-to-volume ratio were significantly reduced. The qPCR analysis revealed a significant down-regulation of bfmR, bap, csuA/B, and ompA expression, which positively correlated with the biofilm's biomass, maximum thickness, and surface-to-volume ratio in BP-AB strains. Myrtenol significantly improved the susceptibility of BP-AB to the antibiotics amikacin, piperacillin/tazobactam, cefoperazone/sulbactam, and ceftazidime.
Conclusion:
Myrtenol attenuates the BP-AB biofilm formation and virulence by suppressing the expression of bfmR, bap, csuA/B, and ompA.
Insights
Myrtenol effectively inhibits biofilm formation and virulence in blaNDM-1-producing Acinetobacter baumannii (BP-AB) by down-regulating key genes. This natural compound also enhances antibiotic susceptibility, offering a potential strategy against resistant nosocomial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- blaNDM-1-producing Acinetobacter baumannii (BP-AB) is a significant cause of nosocomial infections.
- Biofilm formation and virulence factors contribute to BP-AB's resistance.
- Myrtenol's efficacy against BP-AB biofilm and virulence was previously unconfirmed.
Purpose of the Study:
- To investigate the efficacy of myrtenol in inhibiting biofilm formation in BP-AB.
- To assess myrtenol's impact on BP-AB virulence factors.
- To determine if myrtenol can re-sensitize BP-AB to antibiotics.
Main Methods:
- BP-AB strains were treated with varying concentrations of myrtenol.
- Biofilm inhibition was assessed using crystal violet staining and microscopy.
- Gene expression analysis (qPCR) was performed for biofilm-related genes (bfmR, bap, csuA/B, ompA).
- Antibiotic susceptibility testing was conducted post-myrtenol treatment.
Main Results:
- Myrtenol significantly inhibited BP-AB biofilm formation at concentrations of 200 μg/mL and above.
- Microscopy confirmed reduced biofilm biomass, surface area, and thickness.
- Myrtenol down-regulated bfmR, bap, csuA/B, and ompA gene expression.
- Myrtenol treatment enhanced BP-AB susceptibility to several antibiotics.
Conclusions:
- Myrtenol effectively attenuates BP-AB biofilm formation and virulence.
- The mechanism involves suppressing bfmR, bap, csuA/B, and ompA expression.
- Myrtenol shows potential as an adjuvant therapy to combat antibiotic-resistant BP-AB infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Biological Methods for Microbial Control
Antimicrobial Effectiveness

